Sample size requirement in trials that use the composite endpoint major adverse cardiovascular events (MACE): new insights
Marsal, Josep Ramon, Urreta-Barallobre, Iratxe, Ubeda-Carrillo, Marimar, Osorio, Dimelza, Lumbreras, Blanca, Lora, David, Fernández-Felix, Borja M, Oristrell, Gerard, Ródenas-Alesina, Eduard, Herrador, Lorena, Ballesteros, Mónica, Zamora, Javier, Pijoan, Jose I, Ribera, Aida, Ferreira-González, Ignacio
Published in Current controlled trials in cardiovascular medicine (21.12.2022)
Published in Current controlled trials in cardiovascular medicine (21.12.2022)
Get full text
Journal Article